AKTSAktis Oncology, Inc.
$18.14
$18.14
$15.1952 weeks$31.15
AKTS in its own filings
Nothing in AKTS's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
8
Events found in the filings · across 62 filings · the record starts in 2026
- Hard flags
- none
Hard flags
- Most recent filing
- Aug 13, 2026
Most recent filing · Form 10-Q
- Record starts
- Jan 12, 2026
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filinga quarter after the last one
- expected around Nov 12, 2026
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 13, 2026Aktis Oncology Reports Financial Results and Business Highlights for the Second Quarter 2026.Earnings release · press release
- May 11, 2026Aktis Oncology Reports Financial Results and Business Highlights For First Quarter 2026.Earnings release · press release
- Apr 16, 2026Appointment of Glenn Gormley to the Board of Directors On April 15, 2026, the board of directors (the “Board”) of Aktis Oncology, Inc. (the “Company”) appointed Glenn Gormley, MD, PhD as a Class I director of the Company, effective immediately.Director or officer change · Form 8-K
- Mar 30, 2026Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results.Earnings release · press release
- Jan 12, 2026Amended and Restated Certificate of Incorporation As previously disclosed in the Registration Statement on Form S-1, as amended (File No. 333-292283) (the “Registration Statement”), of Aktis Oncology, Inc. (the “Company”), and in connection with the completion of the initial public offering (the “IPO”) of the …Charter/bylaw amendment or fiscal-year change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
Biotechnology
The closest names by size in the same industry